2023 Annual Development Strategy Meeting: 2FIRSTS and IEVA

Jan.05.2023
2023 Annual Development Strategy Meeting: 2FIRSTS and IEVA
2FIRSTS and IEVA discussed e-cigarette industry development strategies for 2023 in an online meeting on January 5th, 2023.

On January 5th, 2023, 2FIRSTS and IEVA held an online meeting to discuss their annual development strategy for the year. The attendees included 2FIRSTS CEO Tong Zhao, COO Xiaoyu Guo, International Public Relations Manager Jason Tian, and 2FIRSTS' Chinese and International Editors, Yuhua Hou and Zhuhong Xu, as well as IEVA President Dustin Dahlmann and board members, Finance and Membership Manager Ciprian Boboi, and Media Relations Manager Philip Drögemüller. The agenda for the meeting was as follows:


IEVA is planning to shoot a global documentary about the electronic cigarette industry and sought advice from 2FIRSTS regarding filming and production. Guo Xiaoyu shared his experience as a supervising producer and director of the documentary "20 Years of Atomization" with IEVA, while Zhao Tong added that the documentary would have a positive impact on the industry.


Both parties have engaged in in-depth discussions and research on the commercial feasibility of recycling disposable electronic cigarettes.


Zhao Tong shared the latest regulatory developments and market conditions in the Chinese electronic cigarette industry for 2022 and provided predictions for relevant matters in 2023.


4. 2FIRSTS and IEVA discussed and strengthened their future cooperation plans during their meeting.


During the meeting, IEVA expressed a desire to obtain 2FIRSTS' database of licensed companies, which would aid in the compliant development of the European electronic cigarette industry.


The editor-in-chief of 2FIRSTS also interviewed Cipri regarding the electronic cigarette market in Europe. 2FIRSTS will continue to stay in contact and communicate with IEVA, keeping a close eye on the European electronic cigarette market. With the partnership of IEVA, they will work together to promote the healthy and compliant development of the electronic cigarette industry in China and Europe.


For more news on IEVA and the European electronic cigarette market, please follow 2FIRSTS.


Ieva and 2FIRSTS host seminar in London: Europe is considering stricter regulation of disposable electronic cigarettes, and after three years, the European E-Cigarette Council has met with the European Electronic Cigarette Association again.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches
CSUR, the Research Institute Supporting Juul’s PMTA Research, Outlines a New Pathway for Nicotine Pouches
CSUR—the Research Institute Supporting Juul and NJOY’s successful PMTAs—assessed FDA’s pilot for nicotine pouches. The program expedites premarket review by deferring behavioral data to post-market reporting. CSUR says this could speed authorizations, but manufacturers must still produce behavioral and real-world evidence after a Marketing Granted Order to maintain compliance with public-health standards.
Nov.04
BAT Pauses U.S. Launch of Unlicensed Vuse One Vape amid FDA Crackdown — Reuters
BAT Pauses U.S. Launch of Unlicensed Vuse One Vape amid FDA Crackdown — Reuters
British American Tobacco has paused the U.S. pilot launch of its unlicensed Vuse One vape amid intensified FDA enforcement.
Oct.28 by 2FIRSTS.ai
Imperial Brands launches ZONE nicotine pouches in the UK, covering the core 9–12 mg strength segment
Imperial Brands launches ZONE nicotine pouches in the UK, covering the core 9–12 mg strength segment
Imperial Brands has launched its ZONE nicotine pouches in the UK, targeting the mainstream 9–12 mg nicotine strength segment. The brand debuts with five flavours at a recommended retail price of £6.50 per can. Mint variants currently account for around 70% of UK nicotine pouch sales, while fruit flavours are growing rapidly. ZONE will be distributed primarily through independent retail channels.
Nov.18 by 2FIRSTS.ai
Indonesian Police to Crack Down on Etomidate-Laced Vapes
Indonesian Police to Crack Down on Etomidate-Laced Vapes
Indonesia’s National Police Criminal Investigation Department (Bareskrim Polri) will continue to take enforcement action against users and distributors of etomidate-laced vape liquids, even though the substance is not yet classified as a narcotic. Brigadier General Eko Hadi Santoso, Director of Narcotics Crimes, said etomidate is an anaesthetic drug regulated under Health Law No. 17 of 2023, but has not been listed as a narcotic or psychotropic substance.
Oct.23 by 2FIRSTS.ai
Imperial Brands FY25 Results: NGP Net Revenue Up 13.7%, Americas Surges Nearly 70%
Imperial Brands FY25 Results: NGP Net Revenue Up 13.7%, Americas Surges Nearly 70%
Imperial Brands reported FY25 NGP net revenue of £368 million, up 13.7% at constant currency. Growth in the Americas accelerated sharply, with NGP revenue up 69.8%, driven by the expansion of the modern oral brand Zone. Europe delivered 8.8% growth, supported by blu’s double-digit vapour share across key markets. Adjusted NGP operating losses narrowed to £76 million, putting the category closer to breakeven.
Nov.18 by 2FIRSTS.ai
Bangladesh Tobacco Control Group Urges Reversal of Philip Morris Nicotine Pouch Factory Approval
Bangladesh Tobacco Control Group Urges Reversal of Philip Morris Nicotine Pouch Factory Approval
Advocates say the economic authority’s decision contradicts national health goals and violates a Supreme Court directive banning new tobacco ventures.
Oct.27 by 2FIRSTS.ai